Singapore markets open in 4 hours 29 minutes
Straits Times Index
3,111.65 +18.85 (+0.61%) S&P 500
3,911.74 +116.01 (+3.06%) Dow
31,500.68 +823.28 (+2.68%) Nasdaq
11,607.62 +375.42 (+3.34%) BTC-USD
21,262.88 +70.67 (+0.33%) CMC Crypto 200
462.12 +8.22 (+1.81%)
Roche Holding AG (RHHBF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:29PM EDT
| Previous close | 350.00 |
| Open | 370.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 370.00 - 388.00 |
| 52-week range | 340.10 - 473.65 |
| Volume | |
| Avg. volume | 753 |
| Market cap | 335.663B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 23.42 |
| EPS (TTM) | 16.57 |
| Earnings date | N/A |
| Forward dividend & yield | 9.97 (2.80%) |
| Ex-dividend date | 17 Mar 2022 |
| 1y target est | N/A |
- Zacks
Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051
The FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following a report of hypomagnesemia in the ongoing phase II MOMENTUM study.
- Zacks
Exelixis (EXEL) Begins Study on XL092 Combo in Colorectal Cancer
Exelixis (EXEL) starts the phase III STELLAR-303 study evaluating XL092 in combination with atezolizumab as compared to regorafenib for treating patients with metastatic colorectal cancer.
- Zacks
The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna
Lilly, Merck, Roche, Pfizer and Moderna have been included in this Analyst Blog.
© 2022 Yahoo. All rights reserved.
